Your browser doesn't support javascript.
loading
Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients.
Aiello, Edoardo Nicolò; Solca, Federica; Greco, Lucia Catherine; Torre, Silvia; Carelli, Laura; Morelli, Claudia; Doretti, Alberto; Colombo, Eleonora; Messina, Stefano; Pain, Debora; Radici, Alice; Lizio, Andrea; Casiraghi, Jacopo; Cerri, Federica; Woolley, Susan; Murphy, Jennifer; Tremolizzo, Lucio; Appollonio, Ildebrando; Verde, Federico; Sansone, Valeria Ada; Lunetta, Christian; Silani, Vincenzo; Ticozzi, Nicola; Poletti, Barbara.
Afiliação
  • Aiello EN; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Solca F; PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Greco LC; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Torre S; Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.
  • Carelli L; NeMO Lab, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Morelli C; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Doretti A; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Colombo E; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Messina S; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Pain D; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Radici A; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Lizio A; Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Department of Milan Institute, Milan, Italy.
  • Casiraghi J; Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Department of Milan Institute, Milan, Italy.
  • Cerri F; Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.
  • Woolley S; Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.
  • Murphy J; Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.
  • Tremolizzo L; Syneos Health, Morrisville, NC, USA.
  • Appollonio I; Biogen, Cambridge, MA, USA.
  • Verde F; School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Sansone VA; School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Lunetta C; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, MI, Italy.
  • Silani V; Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milan, Italy.
  • Ticozzi N; Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.
  • Poletti B; Department of Biomedical Sciences of Health, University of Milan, Milan, Italy.
J Neurol ; 270(8): 4090-4095, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37147520
ABSTRACT

BACKGROUND:

The present study aimed at deriving equating norms to estimate scores on the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) based on those on the ALS Cognitive Behavioral Screen (ALS-CBS™) in an Italian cohort of non-demented ALS patients.

METHODS:

ALS-CBS™ and ECAS scores of 293 ALS patients without frontotemporal dementia were retrospectively retrieved. Concurrent validity of the ALS-CBS™ towards the ECAS was tested by covarying for demographics, disease duration and severity, presence of C9orf72 hexanucleotide repeat expansion and behavioural features. A linear-smoothing equipercentile equating (LSEE) model was employed to derive ALS-CBS™-to-ECAS cross-walks. Gaps in LSEE-based estimation were managed via a linear regression-based equating approach. Equivalence between empirical and derived ECAS scores was tested via a two-one-sided test (TOST) procedure for the dependent sample.

RESULTS:

The ALS-CBS™ predicted the ECAS (ß = 0.75), accounting for the vast majority of its variance (60% out of an R2 = 0.71). Consistently, a strong, one-to-one linear association between ALS-CBS™ and ECAS scores was detected (r = 0.84; R2 = 0.73). The LSEE was able to estimate conversions for the full range of the ALS-CBS™, except for raw scores equal to 1 and 6 - for whom a linear equating-based equation was derived. Empirical ECAS scores were equivalent to those derived with both methods.

DISCUSSION:

Italian practitioners and researchers have been herewith provided with valid, straightforward cross-walks to estimate the ECAS based on ALS-CBS™ scores in non-demented ALS patients. Conversions herewith provided will help avoid cross-sectional/longitudinal inconsistencies in test adoption within research, and possibly clinical, settings.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Esclerose Lateral Amiotrófica Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Esclerose Lateral Amiotrófica Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália